GLP-1s Explained: Why They’re More Than an Appetite Suppressant

GLP-1 is one of the most talked-about drugs of the decade, and your gut already makes it after every meal. In the first episode of Clinically Well, Tiffany Bailey, PA-C, and Dr. Pat Taylor, MD, MSCP, Chief Medical Officer at Belle, break down how GLP-1s work, why insulin resistance is the real root of the problem, and what the research says about the risks.

In this episode:

• How insulin resistance can build for years before blood sugar ever changes
• Natural GLP-1 vs. GLP-1 medications, and why half-life matters
• Why GLP-1s work differently from older weight loss drugs like phentermine
• Obesity as a chronic disease, not a willpower problem
• Research on heart health, sleep apnea, fatty liver, and kidney disease
• Muscle loss on GLP-1s: how protein and strength training can cut it roughly in half
• Myth-busting pancreatitis, thyroid cancer, and bone density concerns
• Weight regain after stopping, and why treatment may be long-term

Next week: midlife metabolic health, how HRT and GLP-1s work together, and why your body can change in midlife even when your diet and exercise don’t.

Clinically Well is your guide to metabolism, hormones, and longevity, presented by Belle Health. Have a question for a future episode? Send it our way.

This podcast is for educational purposes only and is not medical advice. Talk to your own clinician about what’s right for you.

00:00 Welcome to Clinically Well

00:29 The hormone your gut already makes

00:42 How insulin resistance builds years before diabetes

04:46 Meet Dr. Pat and Tiffany

07:57 Dr. Pat's 100-pound weight loss story and his early GLP-1 bias

09:23 There's no trophy for doing it the hard way

09:48 How GLP-1s work in the body

13:24 Oral vs. injectable GLP-1 options

14:26 GLP-1s vs. older weight loss drugs like phentermine

15:50 Obesity is a chronic disease, not a willpower problem

19:53 Insulin resistance, explained simply

21:14 Benefits beyond weight loss: heart health

23:30 Sleep apnea research

23:55 Fatty liver and kidney disease

25:25 Why one mechanism helps so many conditions

28:34 What "off-label" really means

29:48 Will you lose muscle on a GLP-1?

33:50 Myth-busting pancreatitis, thyroid cancer, and bone density

36:28 Weight regain after stopping

37:18 Why treatment may be long-term

38:19 Next week: midlife metabolic health, HRT, and GLP-1s